bpc-157 arginine salt capsules BPC-157 Delayed - 250mcg -

Our staff is trained in intravenous Vitamin C administration and follows strict IV protocols before, during, and after each infusion

The cancer concern around BPC-157 is theoretical, based on its angiogenic properties

Systemic reactions (unusual fatigue, nausea, dizziness) rare but possible

For BPC-157, none of these steps can be performed with the same level of mechanistic confidence because the primary molecular target if a single primary target exists has not been identified in the published literature

BPC-157 (Body Protection Compound-157) consists of the amino acid sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val